Beauty

Shiseido to Sell China's Aupres Business to IDG Capital-Led Consortium

The Japanese group is divesting Shiseido Liyuan Cosmetics, including its Beijing factory, as it refocuses resources on priority brands under its 2030 strategy.

Evelina SandbergNovember 19, 20265 min read2 views
An editorial illustration of a cosmetics production hall in which anonymised business figures exchange a document folder, symbolising the transfer of a beauty business to new owners.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-headquartered private equity firm IDG Capital. The unit manufactures and sells the Aupres brand in China. Financial terms of the transaction were not disclosed.

The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China.

Ownership and handover arrangements

Under the agreement, funds managed by IDG Capital will hold 95% of the equity through two special purpose vehicles, while a limited partnership enterprise set up mainly by SLC's incoming management team will take the remaining 5%. The sale includes SLC's Beijing factory and production equipment.

Shiseido said it will license the intellectual property rights IDG needs to operate the business. For a specified period after the transfer, the group will also provide support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. Shiseido presents these arrangements as a way to maintain SLC's innovation capabilities, product quality and business continuity.

The strategic rationale

The sale sits within Shiseido's 2030 Medium-Term Strategy, which targets improved profitability and capital efficiency. The group said it wants to concentrate management resources on areas where it "enjoys the greatest competitive advantage", and to focus on priority brands and higher-growth opportunities.

According to Shiseido, SLC is a business that requires continued investment in product innovation and digital capabilities. The company expects independent operation under IDG to support the subsidiary's sustainable growth and brand value — an expectation rather than a demonstrated result.

Shiseido described China as a strategically important and dynamic market, where the competitive landscape continues to evolve amid rapid e-commerce expansion, changing consumer behaviour and the emergence of diverse market participants.

From joint venture to full ownership

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. It has sold the C-beauty brand Aupres since 1994. With the joint venture agreement due to expire in December 2026, the parties agreed not to renew it. Instead, on September 1, 2026, Shiseido acquired Beijing Liyuan's 35% stake, giving it full ownership ahead of the sale.

Timing against a profit recovery

The divestment comes days after Shiseido reported a 124.3% year-on-year rise in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The company attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%.

On the back of those results, Shiseido raised its full-year core operating profit forecast to ¥87 billion (US$546 million) from ¥59 billion (US$433 million).